Trial Profile
A Phase I/II Trial of Transbuccal Testosterone Replacement Product (MSRX-110) in Patients with Hypogonadism
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Aquestive Therapeutics
- 30 Nov 2017 According to a Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics
- 12 Feb 2015 New trial record